Thu. 9 May 2024, 4:36pm ET
Benzinga
Earnings, Earnings Beats, News
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.85) by 45.88 percent. The company reported quarterly sales of $168.500 million which beat the analyst consensus estimate of $150.673 million by 11.83 percent. This is a 30.91 percent increase over sales of $128.714 million the same period last year.